1 – 10 of 171
      - show: 10
 - |
 - sort: year (new to old)
 
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2025
 - 
                        Mark
        Gene expression-based identification of prognostic markers in lung adenocarcinoma
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Genomic characterization of the HER2-enriched intrinsic molecular subtype in primary ER-positive HER2-negative breast cancer
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        The DNA methylation landscape of primary triple-negative breast cancer
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        FHL2 expression by cancer-associated fibroblasts promotes metastasis and angiogenesis in lung adenocarcinoma
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Evaluation of alternative prognostic thresholds for SP142 and 22C3 immunohistochemical PD-L1 expression in triple-negative breast cancer : results from a population-based cohort
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        A two-phase epigenome-wide four-way gene–smoking interaction study of overall survival for early-stage non-small cell lung cancer
    
    
- Contribution to journal › Article
 
 - 2024
 - 
                        Mark
        The analytical and clinical validity of AI algorithms to score TILs in TNBC : can we use different machine learning models interchangeably?
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Kataegis in clinical and molecular subgroups of primary breast cancer
    (2024) European Association for Cancer Research
- Contribution to conference › Poster
 
 - 
                        Mark
        Kataegis in clinical and molecular subgroups of primary breast cancer
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Current and emerging sequencing-based tools for precision cancer medicine
    
    
- Contribution to journal › Scientific review
 
 
